MX9603510A - (-)-liarozol enantiomericamente puro. - Google Patents
(-)-liarozol enantiomericamente puro.Info
- Publication number
- MX9603510A MX9603510A MX9603510A MX9603510A MX9603510A MX 9603510 A MX9603510 A MX 9603510A MX 9603510 A MX9603510 A MX 9603510A MX 9603510 A MX9603510 A MX 9603510A MX 9603510 A MX9603510 A MX 9603510A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- liarozole
- enantiomerically pure
- novel
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Esta invencion se refiere al isomero levogiro enantioméricamente puro novedoso de la formula I (Ver Formula) y las formas de sal ácida de adicion farmacéuticamente aceptable del mismo; estos compuestos son particularmente utiles para tratar trastornos que se caracterizan por una proliferacion incrementada y/o diferenciacion anormal de células epiteliales normales, preneoplásticas o neoplásticas; los compuestos de la formula (I) son particularmente utiles en el campo de la oncología; también se describen composiciones que contienen dichos compuestos novedosos, métodos para preparar dichos compuestos novedosos así como métodos para usar los compuestos mencionados para tratar los trastornos mencionados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94200418 | 1994-02-18 | ||
PCT/EP1995/000491 WO1995022541A1 (en) | 1994-02-18 | 1995-02-10 | Enantiomerically pure(-)-liarozole |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603510A true MX9603510A (es) | 1997-03-29 |
Family
ID=8216651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603510A MX9603510A (es) | 1994-02-18 | 1995-02-10 | (-)-liarozol enantiomericamente puro. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0745078A1 (es) |
JP (1) | JPH09508915A (es) |
CN (1) | CN1141041A (es) |
AU (1) | AU688852B2 (es) |
IL (1) | IL112689A0 (es) |
MX (1) | MX9603510A (es) |
NZ (1) | NZ279228A (es) |
SG (1) | SG47122A1 (es) |
TW (1) | TW418203B (es) |
WO (1) | WO1995022541A1 (es) |
ZA (1) | ZA951342B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1992228A1 (en) * | 2007-05-14 | 2008-11-19 | Bayer CropScience AG | Insecticidal substituted thiourea derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
CA2002859C (en) * | 1988-11-29 | 1998-12-29 | Jean P. F. Van Wauwe | Method of treating epithelial disorders |
-
1995
- 1995-02-10 MX MX9603510A patent/MX9603510A/es unknown
- 1995-02-10 TW TW084101154A patent/TW418203B/zh active
- 1995-02-10 NZ NZ279228A patent/NZ279228A/en unknown
- 1995-02-10 EP EP95907663A patent/EP0745078A1/en not_active Withdrawn
- 1995-02-10 CN CN95191667A patent/CN1141041A/zh active Pending
- 1995-02-10 AU AU15788/95A patent/AU688852B2/en not_active Expired - Fee Related
- 1995-02-10 SG SG1996009264A patent/SG47122A1/en unknown
- 1995-02-10 JP JP7521564A patent/JPH09508915A/ja active Pending
- 1995-02-10 WO PCT/EP1995/000491 patent/WO1995022541A1/en not_active Application Discontinuation
- 1995-02-17 ZA ZA951342A patent/ZA951342B/xx unknown
- 1995-02-17 IL IL11268995A patent/IL112689A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA951342B (en) | 1996-08-19 |
EP0745078A1 (en) | 1996-12-04 |
JPH09508915A (ja) | 1997-09-09 |
IL112689A0 (en) | 1995-05-26 |
TW418203B (en) | 2001-01-11 |
CN1141041A (zh) | 1997-01-22 |
NZ279228A (en) | 1997-11-24 |
WO1995022541A1 (en) | 1995-08-24 |
AU688852B2 (en) | 1998-03-19 |
AU1578895A (en) | 1995-09-04 |
SG47122A1 (en) | 1998-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3036816T3 (en) | Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes | |
YU95102A (sh) | Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija | |
EA200200509A1 (ru) | Новые производные бензоимидазола, используемые в качестве антипролиферативного средства | |
ATE175194T1 (de) | (e)-20(22)-dehydrovitamin-d-verbindungen | |
HUT70499A (en) | Fluoroalkoxybenzaldehyde derivatives and process for producing them | |
MXPA05006420A (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal. | |
RS20050180A (en) | Novel benzoimidazole derivatives useful as antiproliferative agensts | |
ZA975439B (en) | New pyridyl alkane acid amides. | |
EP0807633A3 (en) | Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones | |
TR200000673T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
NZ512526A (en) | 4-sulfonamido-6-sulfamidoalkoxypyrimidine derivatives, pharmaceuticals thereof, and their use for the treatment of disorders associated with a role of endothelin. | |
BG100661A (en) | Aryl acetic acid derivatives | |
PL336640A1 (en) | Substituted 3,3-diamino-2- propenonitriles, their production and application | |
ES8606347A1 (es) | Un procedimiento para preparar derivados de purina | |
IL166103A0 (en) | Pyrrolidine derivatives and their use | |
MX9603316A (es) | (+)-liarozol enantiomericamente puro. | |
MX9603510A (es) | (-)-liarozol enantiomericamente puro. | |
MX9704704A (es) | Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su obtencion, medicamentos que contienen estos compuestos, y su utilizacion. | |
TNSN86165A1 (fr) | Nouveaux ortho-anisamides, leur procede d'obtention et leurs applications therapeutiques | |
CA2208032A1 (en) | Substituted amidinonaphthyl ester derivative | |
ZA944317B (en) | New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
ATE168683T1 (de) | Substituierte iminoacetonitrile mit myokardprotektiver wirkung |